| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 3.53e-05 | 4 | 49 | 2 | GO:0030197 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.58e-06 | 109 | 49 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.96e-05 | 94 | 49 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.03e-04 | 104 | 49 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.24e-04 | 109 | 49 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.60e-04 | 45 | 49 | 3 | GO:1902562 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.48e-03 | 96 | 49 | 3 | GO:0070603 | |
| Domain | SEA | 2.55e-05 | 23 | 47 | 3 | PS50024 | |
| Domain | SEA_dom | 2.55e-05 | 23 | 47 | 3 | IPR000082 | |
| Domain | SEA | 5.53e-04 | 14 | 47 | 2 | SM00200 | |
| Domain | VWD | 7.27e-04 | 16 | 47 | 2 | SM00216 | |
| Domain | VWF_type-D | 7.27e-04 | 16 | 47 | 2 | IPR001846 | |
| Domain | VWFD | 7.27e-04 | 16 | 47 | 2 | PS51233 | |
| Domain | VWD | 7.27e-04 | 16 | 47 | 2 | PF00094 | |
| Domain | SEA | 1.39e-03 | 22 | 47 | 2 | PF01390 | |
| Domain | EGF_1 | 3.82e-03 | 255 | 47 | 4 | PS00022 | |
| Domain | EGF-like_CS | 4.15e-03 | 261 | 47 | 4 | IPR013032 | |
| Domain | EGF_2 | 4.38e-03 | 265 | 47 | 4 | PS01186 | |
| Domain | FN3 | 1.13e-02 | 185 | 47 | 3 | SM00060 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 5.67e-08 | 16 | 35 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 7.40e-08 | 17 | 35 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.73e-07 | 23 | 35 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.58e-07 | 26 | 35 | 4 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.53e-07 | 68 | 35 | 5 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.43e-06 | 111 | 35 | 5 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.60e-05 | 62 | 35 | 4 | M546 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.81e-05 | 21 | 35 | 3 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.54e-05 | 143 | 35 | 5 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.47e-04 | 109 | 35 | 4 | MM15164 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.54e-04 | 250 | 35 | 5 | M27554 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.84e-04 | 140 | 35 | 4 | M27484 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 4.14e-04 | 59 | 35 | 3 | M46460 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.35e-04 | 60 | 35 | 3 | MM15636 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 8.05e-04 | 74 | 35 | 3 | M48006 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.80e-11 | 18 | 49 | 5 | 18834073 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.41e-09 | 351 | 49 | 9 | 38297188 | |
| Pubmed | 2.86e-07 | 469 | 49 | 8 | 27634302 | ||
| Pubmed | HNF1B SALL1 TCF20 EP400 BCL7C NUP98 GIGYF2 NUP214 ZHX2 TAF12 HCFC1 ZNF687 | 4.97e-07 | 1429 | 49 | 12 | 35140242 | |
| Pubmed | 7.03e-07 | 222 | 49 | 6 | 37071664 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 8.58e-07 | 123 | 49 | 5 | 26912792 | |
| Pubmed | 1.61e-06 | 407 | 49 | 7 | 12693553 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.61e-06 | 256 | 49 | 6 | 33397691 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23544943 | ||
| Pubmed | 2.10e-06 | 268 | 49 | 6 | 33640491 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23053434 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 9847314 | ||
| Pubmed | Expression of mucin (MUC) genes in mucoepidermoid carcinoma. | 5.83e-06 | 3 | 49 | 2 | 21072847 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 30236127 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 35879412 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 12589057 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 5.83e-06 | 3 | 49 | 2 | 21327100 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 5.83e-06 | 3 | 49 | 2 | 17592322 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 8943370 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16971658 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27483328 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24204560 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26770020 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24939955 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 5.97e-06 | 497 | 49 | 7 | 36774506 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TCF20 MAP7D3 EP400 NUP98 NCAPH2 NUP214 TAF12 AHDC1 HCFC1 ZNF687 | 1.07e-05 | 1294 | 49 | 10 | 30804502 |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 1.16e-05 | 4 | 49 | 2 | 39024979 | |
| Pubmed | In vitro analysis of nuclear transport mediated by the C-terminal shuttle domain of Tap. | 1.16e-05 | 4 | 49 | 2 | 11551912 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 9368759 | ||
| Pubmed | Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence. | 1.16e-05 | 4 | 49 | 2 | 30543681 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.17e-05 | 774 | 49 | 8 | 15302935 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 19828735 | ||
| Pubmed | 2.63e-05 | 418 | 49 | 6 | 34709266 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 14983011 | ||
| Pubmed | Karyopherin beta2 mediates nuclear import of a mRNA binding protein. | 2.91e-05 | 6 | 49 | 2 | 9144189 | |
| Pubmed | Cessation of HIV-1 transcription by inhibiting regulatory protein Rev-mediated RNA transport. | 2.91e-05 | 6 | 49 | 2 | 19149559 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 19110483 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.08e-05 | 430 | 49 | 6 | 35044719 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 3.90e-05 | 134 | 49 | 4 | 25452129 | |
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 11238447 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 5.18e-05 | 954 | 49 | 8 | 36373674 | |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 5.42e-05 | 8 | 49 | 2 | 31375530 | |
| Pubmed | 6.07e-05 | 486 | 49 | 6 | 20936779 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 9114010 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.49e-05 | 1024 | 49 | 8 | 24711643 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 19581287 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 9.18e-05 | 167 | 49 | 4 | 20362541 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.04e-04 | 332 | 49 | 5 | 32786267 | |
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 36579465 | ||
| Pubmed | 1.10e-04 | 175 | 49 | 4 | 28071719 | ||
| Pubmed | 1.15e-04 | 339 | 49 | 5 | 30415952 | ||
| Pubmed | Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. | 1.27e-04 | 12 | 49 | 2 | 15749018 | |
| Pubmed | 1.31e-04 | 808 | 49 | 7 | 20412781 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.46e-04 | 357 | 49 | 5 | 37059091 | |
| Pubmed | 1.46e-04 | 72 | 49 | 3 | 36376293 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.48e-04 | 1425 | 49 | 9 | 30948266 | |
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 11073998 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.94e-04 | 203 | 49 | 4 | 22083510 | |
| Pubmed | 2.36e-04 | 396 | 49 | 5 | 26687479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.41e-04 | 398 | 49 | 5 | 35016035 | |
| Pubmed | 2.61e-04 | 17 | 49 | 2 | 10668806 | ||
| Pubmed | 2.66e-04 | 638 | 49 | 6 | 31182584 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.80e-04 | 411 | 49 | 5 | 35182466 | |
| Pubmed | 2.82e-04 | 645 | 49 | 6 | 25281560 | ||
| Pubmed | Architectural niche organization by LHX2 is linked to hair follicle stem cell function. | 2.93e-04 | 18 | 49 | 2 | 24012369 | |
| Pubmed | 3.01e-04 | 653 | 49 | 6 | 22586326 | ||
| Pubmed | 3.27e-04 | 19 | 49 | 2 | 20161779 | ||
| Pubmed | 3.27e-04 | 19 | 49 | 2 | 24165912 | ||
| Pubmed | 3.34e-04 | 234 | 49 | 4 | 36243803 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.98e-04 | 444 | 49 | 5 | 34795231 | |
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 4.41e-04 | 22 | 49 | 2 | 29449451 | |
| Pubmed | 4.41e-04 | 22 | 49 | 2 | 38014633 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.54e-04 | 457 | 49 | 5 | 32344865 | |
| Pubmed | 4.63e-04 | 708 | 49 | 6 | 39231216 | ||
| Pubmed | 4.83e-04 | 23 | 49 | 2 | 9225980 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 4.91e-04 | 1005 | 49 | 7 | 19615732 | |
| Pubmed | 4.93e-04 | 1327 | 49 | 8 | 32694731 | ||
| Pubmed | 5.18e-04 | 1014 | 49 | 7 | 32416067 | ||
| Pubmed | Mitochondrial antiviral-signalling protein is a client of the BAG6 protein quality control complex. | 5.26e-04 | 24 | 49 | 2 | 35543156 | |
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 5.26e-04 | 24 | 49 | 2 | 26116661 | |
| Pubmed | 5.26e-04 | 24 | 49 | 2 | 32212159 | ||
| Pubmed | The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. | 5.71e-04 | 25 | 49 | 2 | 19240132 | |
| Pubmed | 5.71e-04 | 25 | 49 | 2 | 36708875 | ||
| Pubmed | 5.71e-04 | 25 | 49 | 2 | 10601273 | ||
| Pubmed | 6.18e-04 | 26 | 49 | 2 | 12228227 | ||
| Pubmed | 6.18e-04 | 26 | 49 | 2 | 29712641 | ||
| Pubmed | 6.67e-04 | 27 | 49 | 2 | 18838386 | ||
| Pubmed | 6.73e-04 | 121 | 49 | 3 | 22412018 | ||
| Pubmed | 7.00e-04 | 503 | 49 | 5 | 16964243 | ||
| Pubmed | 8.25e-04 | 30 | 49 | 2 | 20083228 | ||
| Pubmed | 8.50e-04 | 1103 | 49 | 7 | 34189442 | ||
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 8.79e-04 | 303 | 49 | 4 | 25056061 | |
| Pubmed | Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome. | 8.81e-04 | 31 | 49 | 2 | 15778864 | |
| Pubmed | 8.81e-04 | 31 | 49 | 2 | 22711842 | ||
| Pubmed | BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. | 8.81e-04 | 31 | 49 | 2 | 23086144 | |
| Pubmed | 9.39e-04 | 32 | 49 | 2 | 20610746 | ||
| Pubmed | 1.04e-03 | 549 | 49 | 5 | 38280479 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.04e-03 | 1489 | 49 | 8 | 28611215 | |
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 1.06e-03 | 34 | 49 | 2 | 18539113 | |
| Pubmed | 1.12e-03 | 35 | 49 | 2 | 15031101 | ||
| Interaction | CRX interactions | 2.20e-06 | 254 | 48 | 7 | int:CRX | |
| Interaction | NUP43 interactions | 1.42e-05 | 625 | 48 | 9 | int:NUP43 | |
| Interaction | NFIX interactions | 1.58e-05 | 227 | 48 | 6 | int:NFIX | |
| Interaction | HDAC1 interactions | FLNB HNF1B SALL1 TCF20 EP400 NUP98 GIGYF2 NUP214 ZHX2 HCFC1 ZNF687 | 4.55e-05 | 1108 | 48 | 11 | int:HDAC1 |
| Interaction | POU5F1 interactions | 6.43e-05 | 584 | 48 | 8 | int:POU5F1 | |
| Interaction | CLEC11A interactions | 8.01e-05 | 96 | 48 | 4 | int:CLEC11A | |
| Interaction | SUZ12 interactions | 1.27e-04 | 644 | 48 | 8 | int:SUZ12 | |
| Interaction | PHLPP1 interactions | 1.33e-04 | 333 | 48 | 6 | int:PHLPP1 | |
| GeneFamily | CD molecules|Mucins | 2.50e-10 | 21 | 32 | 5 | 648 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.88e-04 | 25 | 32 | 2 | 775 | |
| GeneFamily | Nucleoporins | 1.46e-03 | 32 | 32 | 2 | 1051 | |
| Coexpression | NABA_ECM_AFFILIATED | 6.67e-07 | 170 | 48 | 6 | M5880 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 2.16e-05 | 184 | 48 | 5 | M19988 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.67e-07 | 155 | 49 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-06 | 174 | 49 | 5 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.57e-05 | 137 | 49 | 4 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.96e-05 | 145 | 49 | 4 | 78f5f4b96420c7f391e4d32a9ed151ed95fad90b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.12e-05 | 148 | 49 | 4 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.65e-05 | 170 | 49 | 4 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.82e-05 | 172 | 49 | 4 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.91e-05 | 173 | 49 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-05 | 176 | 49 | 4 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-05 | 179 | 49 | 4 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.66e-05 | 181 | 49 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.76e-05 | 182 | 49 | 4 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.86e-05 | 183 | 49 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-05 | 188 | 49 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.40e-05 | 188 | 49 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.51e-05 | 189 | 49 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 189 | 49 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 190 | 49 | 4 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 190 | 49 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.74e-05 | 191 | 49 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.74e-05 | 191 | 49 | 4 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 193 | 49 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.98e-05 | 193 | 49 | 4 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.10e-05 | 194 | 49 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.10e-05 | 194 | 49 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.10e-05 | 194 | 49 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.10e-05 | 194 | 49 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 6.22e-05 | 195 | 49 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.35e-05 | 196 | 49 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.47e-05 | 197 | 49 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 6.47e-05 | 197 | 49 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.60e-05 | 198 | 49 | 4 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.86e-05 | 200 | 49 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cacng4_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.07e-05 | 76 | 49 | 3 | 4afc8d0e79870c635a89dd8e7ca91ebfe482b4ab | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.50e-04 | 136 | 49 | 3 | 9cf076597e6fd9390850fda259daa13022f15893 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.59e-04 | 137 | 49 | 3 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.59e-04 | 137 | 49 | 3 | 47859aa25f32367461c1ec75ed9060bee430c6b7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-04 | 145 | 49 | 3 | 6f6e08b1234a08f94bd17c11d267f39eabb10068 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.75e-04 | 148 | 49 | 3 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.33e-04 | 153 | 49 | 3 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-04 | 155 | 49 | 3 | fa2776d258e0420b2895de1008e292ad7725dac0 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.58e-04 | 155 | 49 | 3 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-04 | 155 | 49 | 3 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.58e-04 | 155 | 49 | 3 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.08e-04 | 159 | 49 | 3 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.08e-04 | 159 | 49 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.34e-04 | 161 | 49 | 3 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.34e-04 | 161 | 49 | 3 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.61e-04 | 163 | 49 | 3 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.75e-04 | 164 | 49 | 3 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.02e-04 | 166 | 49 | 3 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-04 | 166 | 49 | 3 | 9e916fc1858573358e1eb5e3789b2c9f8ef74476 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-04 | 167 | 49 | 3 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.16e-04 | 167 | 49 | 3 | 720dc5855c856b478b5ca90156b30bfcc5518d60 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.31e-04 | 168 | 49 | 3 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.31e-04 | 168 | 49 | 3 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.31e-04 | 168 | 49 | 3 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-04 | 170 | 49 | 3 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.59e-04 | 170 | 49 | 3 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-04 | 170 | 49 | 3 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 8.59e-04 | 170 | 49 | 3 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 170 | 49 | 3 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 170 | 49 | 3 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.74e-04 | 171 | 49 | 3 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-04 | 173 | 49 | 3 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-04 | 173 | 49 | 3 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-04 | 173 | 49 | 3 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-04 | 174 | 49 | 3 | 8d8cf8ad17dcc364f867e36b10834a21c0e36ad2 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.19e-04 | 174 | 49 | 3 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.19e-04 | 174 | 49 | 3 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.19e-04 | 174 | 49 | 3 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-04 | 174 | 49 | 3 | 62f5dc7086e1491fc90f005ccadfa1b772b52fad | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.19e-04 | 174 | 49 | 3 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.34e-04 | 175 | 49 | 3 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.34e-04 | 175 | 49 | 3 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.34e-04 | 175 | 49 | 3 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.50e-04 | 176 | 49 | 3 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.66e-04 | 177 | 49 | 3 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.66e-04 | 177 | 49 | 3 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.81e-04 | 178 | 49 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.81e-04 | 178 | 49 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.81e-04 | 178 | 49 | 3 | fce60ce6b662f1bdaa3b4da43800c6c22fe89533 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.81e-04 | 178 | 49 | 3 | b19c906e067b07eadfd68934d9330b447e24c708 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.97e-04 | 179 | 49 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.97e-04 | 179 | 49 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 180 | 49 | 3 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-03 | 180 | 49 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-03 | 180 | 49 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-03 | 181 | 49 | 3 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.03e-03 | 181 | 49 | 3 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-03 | 181 | 49 | 3 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 181 | 49 | 3 | 4a0f1b121570430afb100c589657d931184e124f | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 181 | 49 | 3 | 34b49092f71128898af3b311170c4ed8adfefcff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-03 | 182 | 49 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| Drug | cellobiitol | 1.19e-06 | 37 | 49 | 4 | CID000003871 | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 3.54e-06 | 193 | 49 | 6 | 1236_DN | |
| Drug | Gastrin tetrapeptide | 4.05e-06 | 50 | 49 | 4 | CID000005415 | |
| Drug | Tn epitope | 5.96e-06 | 55 | 49 | 4 | CID000447272 | |
| Drug | mucic acid | 3.87e-05 | 88 | 49 | 4 | CID000000607 | |
| Drug | rioprostil | 4.45e-05 | 32 | 49 | 3 | CID005311413 | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 5428_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; HL60; HG-U133A | 6.15e-05 | 195 | 49 | 5 | 1401_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 2388_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 7301_DN | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; HL60; HG-U133A | 6.61e-05 | 198 | 49 | 5 | 1380_UP | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; HL60; HG-U133A | 6.61e-05 | 198 | 49 | 5 | 1392_UP | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5451_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 2120_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; HL60; HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1383_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A | 6.77e-05 | 199 | 49 | 5 | 2045_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; HL60; HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1768_UP | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 7281_DN | |
| Drug | radicicol | 7.44e-05 | 203 | 49 | 5 | CID000005033 | |
| Disease | Developmental regression | 5.64e-05 | 7 | 49 | 2 | C1836830 | |
| Disease | Papillary Renal Cell Carcinoma | 6.15e-05 | 128 | 49 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 6.15e-05 | 128 | 49 | 4 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.15e-05 | 128 | 49 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.15e-05 | 128 | 49 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.15e-05 | 128 | 49 | 4 | C1266044 | |
| Disease | phenol sulfate measurement | 7.52e-05 | 8 | 49 | 2 | EFO_0021011 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.08e-04 | 148 | 49 | 4 | C0279702 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.67e-04 | 64 | 49 | 3 | DOID:4947 (is_marker_for) | |
| Disease | anxiety disorder, stress-related disorder | 1.76e-04 | 12 | 49 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.08e-04 | 13 | 49 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Sjogren's syndrome (is_marker_for) | 7.28e-04 | 24 | 49 | 2 | DOID:12894 (is_marker_for) | |
| Disease | necrotizing enterocolitis | 9.23e-04 | 27 | 49 | 2 | EFO_0003928 | |
| Disease | internet addiction disorder | 1.38e-03 | 33 | 49 | 2 | EFO_0803368 | |
| Disease | Global developmental delay | 1.42e-03 | 133 | 49 | 3 | C0557874 | |
| Disease | bullous pemphigoid | 1.46e-03 | 34 | 49 | 2 | EFO_0007187 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGGPEMASLSSSVVP | 16 | P0C7Q2 | |
| IKTSVTGTSMPTGAV | 2616 | Q96L91 | |
| VGTTVTMTGNGTRPP | 381 | P46379 | |
| SGMGIAVSTPSTQKP | 531 | Q6IC98 | |
| PPKTGAVVIDMGTGT | 46 | Q8TC94 | |
| PSIGPVSRGMKESIS | 2751 | Q96M86 | |
| STVSPGGYMVPKGTT | 1061 | Q5TGY3 | |
| TSGTVTVGPMHTLPS | 1031 | Q00975 | |
| PTTSETGTPRVEGMV | 1226 | P58397 | |
| VGTSAGVVLTMPTSP | 1936 | Q96PE2 | |
| PAGTTIVKTMAVTPG | 571 | P51610 | |
| GGTKPSYTMVSSVIP | 666 | Q8WXI7 | |
| ESTDMAITPKTGPSG | 9361 | Q8WXI7 | |
| PGMVKTTDTSTEPGT | 10056 | Q8WXI7 | |
| MVTSPGVDTRSGVPT | 11606 | Q8WXI7 | |
| AIPVSTGMASSIVPG | 856 | Q99102 | |
| ETPGMTTPSLKTDGG | 4261 | Q99102 | |
| PPTGTDTMVKAGVST | 166 | P52948 | |
| MPVIPKGSSVGTGTN | 541 | Q15139 | |
| LETSKGTSGPPVTMA | 176 | P16150 | |
| STMSPGTVGQSLKSP | 4346 | Q2LD37 | |
| TGEVHMPSGKTATPE | 1761 | O75369 | |
| PIRGPESGGTMVTIT | 961 | O75051 | |
| VTTPEKSPGVAMTTG | 2456 | Q7Z5P9 | |
| MEPPSTTVATTGTGQ | 1336 | Q02505 | |
| SMCFTKPGAEVPTGT | 176 | A6NC86 | |
| PGVMGTSVATSASKI | 1046 | P35658 | |
| SMLPGSGSVPKKSTE | 341 | Q96RT8 | |
| GVRKDASTSPMPTGS | 476 | Q86T90 | |
| GITAGSTDEPPMLTK | 151 | Q8WUZ0 | |
| ETPVVGAPGMGSVST | 466 | Q6Y7W6 | |
| VGSKSEMTASPLVGP | 466 | Q9P0L2 | |
| ASPKAGVGMAPEVST | 321 | Q8IWC1 | |
| LQTGSMVKPVSPAGT | 6 | Q8TC76 | |
| VVPPTTTSGGLIMTS | 406 | P49336 | |
| VGPEMTGVTVSGLTP | 721 | Q7Z5N4 | |
| TLPPSGGKSEESGMV | 616 | Q9NSC2 | |
| KMISVSGGGLPPVST | 401 | P35680 | |
| SLGPMGSVVKSEPSS | 366 | P41225 | |
| MANSTAVVKIPGTPG | 31 | Q16514 | |
| PATIMTSSVPTTVGG | 391 | P11831 | |
| GVSPMPGTQKDTGRT | 206 | Q6IBW4 | |
| PSSGGSGIPEVKTML | 116 | P51801 | |
| SGTMGTKGHTEVIVP | 591 | A0AVT1 | |
| SATVSSSVPMPAGGK | 36 | Q8TB22 | |
| PITGGTPSMVTVDGT | 1746 | P24821 | |
| AETVTAGKEPPGAMT | 1451 | Q9UGU0 | |
| AGKEPPGAMTSTTSQ | 1456 | Q9UGU0 | |
| EVSTMVESPAAPGKG | 421 | Q8IUG5 | |
| TSGGMKPSSVSVPQC | 476 | Q6PKC3 | |
| DSGISVSKTPIMKPG | 176 | Q9Y6X8 | |
| VMVQPSKTATGPSTG | 471 | Q8N1G0 | |
| SSPSAVVVEMGSKPA | 561 | Q8TEC5 | |
| PGSGPMFKSTTVTVR | 131 | Q7Z570 | |
| GSMETTALPGSTTKP | 616 | Q9UKN1 |